BCR and chronic myelogenous leukemia, BCR-ABL1 positive: An example is the use of Gleevec and other Abl kinase inhibitors in chronic myelogenous leukemia (CML) patients that harbor the Philadelphia Chromosome translocation creating a BCR-Abl gain of function fusion protein.